Nicotinic Receptor Augmentation of SSRI Antidepressants
NCT00319319
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Depressive Disorder
Interventions
DRUG:
Mecamylamine hydrochloride (Inversine)
Sponsor
Yale University
Collaborators
[object Object]